Boston Startup Fundraising Looks Strong Only By Pre-AI Parameters
Boston startups raised about $7.8 billion so far this year, but the gain looks modest beside the AI-fueled boom concentrated in San Francisco.
Intelligence analysis by GPT-5.4 Mini
Boston venture funding is up and on pace for its strongest year in about four years, but the comparison looks less impressive because AI mega-rounds have concentrated capital elsewhere. The region still shows strength in biotech and healthcare, even as it lacks a marquee generative AI winner.
Boston’s startup scene is doing pretty well. Companies there have raised a lot of money this year, and it is on track for one of its best years in a while.
But the whole startup game has been changed by giant AI companies. Those firms are raising so much money that other places can look smaller even when they are still growing.
It is like a school race where one runner suddenly gets a scooter. The other runners may still be running fast, but the scoreboard looks strange. Boston is still strong in things like health and biotech, even if it is not home to the biggest AI stars.
Analysis
Boston is up, but AI has changed the scoreboard
Boston-area startups have raised about $7.8 billion so far this year, according to Crunchbase data. That puts the metro on track for a moderate annual increase and its best tally in roughly four years.
The catch is that the broader U.S. venture market has been distorted by enormous AI rounds. North America venture funding reached a record in the first quarter, and more than 87% of that money flowed into AI-related categories. The article argues that this makes Boston’s gains look smaller than they would have in a pre-AI market.
Where Boston is still strong
Boston is not producing the largest generative AI fundraisers, which are mostly based in the San Francisco Bay Area. That means the region missed the splashiest rounds shaping the national narrative. Biotech, long a Boston strength, is also not in a major funding surge, so it cannot offset AI’s scale.
Even so, Boston did produce several large rounds. Whoop led with a $575 million Series G at a $10.1 billion valuation in March. The company says it uses more than 24 billion hours of physiological data and purpose-built AI models for predictive health insights. Cloaked raised $375 million in Series B, and Devoted Health disclosed $366 million across two Series F tranches. More than half of the companies on the list are in biotech or healthcare.
The article’s bottom line is that Boston remains a serious startup hub, especially in biotech and healthcare, but its reputation now gets judged against an AI era that is pulling capital to a few very large coastal winners.
Key points
- Boston-area startups have raised about $7.8 billion so far this year, which puts the region on pace for a moderate gain.
- The article says Boston’s performance looks weaker because AI has pulled an unusually large share of U.S. venture dollars into a few huge rounds.
- Whoop led the region’s funding with a $575 million Series G at a $10.1 billion valuation.
- More than half of the funded companies listed are focused on biotech or healthcare.
- The piece argues Boston still has core strengths, but it lacks a top-tier generative AI winner.
Boston could keep building on its strengths in biotech and healthcare, where the article says it remains an established powerhouse. The presence of very large rounds like Whoop, Cloaked, and Devoted Health suggests the region can still support companies that raise major capital.
If generative AI keeps absorbing most of the venture dollars, Boston may continue to look weak by comparison even when local funding is rising. The article also suggests the region’s reputation suffers without a marquee high-valuation AI company to match the Bay Area leaders.
